<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>exposure windows &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/exposure-windows/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 06 Oct 2026 15:17:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>exposure windows &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Antidepressants and Breast Cancer: Landmark Analysis of Nearly Two Million Women Reveals Timing Matters</title>
		<link>https://bioengineer.org/antidepressants-and-breast-cancer-landmark-analysis-of-nearly-two-million-women-reveals-timing-matters/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 15:17:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[antidepressants]]></category>
		<category><![CDATA[BMC Medicine]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[Cancer Epidemiology]]></category>
		<category><![CDATA[drug safety]]></category>
		<category><![CDATA[exposure windows]]></category>
		<category><![CDATA[Meta-analysis]]></category>
		<category><![CDATA[pharmacoepidemiology]]></category>
		<category><![CDATA[psychopharmacology]]></category>
		<category><![CDATA[risk factors]]></category>
		<category><![CDATA[SSRIs]]></category>
		<category><![CDATA[women's health]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=404414</guid>

					<description><![CDATA[A meta-analysis of twenty-three studies covering nearly 1.83 million women finds that short-term SSRI use is associated with a modest increase in breast cancer risk while prior use of at least one year appears protective, suggesting the antidepressant-breast cancer relationship depends critically on exposure timing and duration.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">404414</post-id>	</item>
	</channel>
</rss>
